How has BioLife Solutions's investments - gross unrealized losses changed year-over-year?

BioLife Solutions's investments - gross unrealized losses increased by 479.6% year-over-year, from $10M to $57.93M.

BioLife Solutions BLFS Investments - Gross Unrealized Losses

Revenue$27.5M+24.7%

Gross profit$17.5M+18.2%

Operating income$27.0K+105%

Net income$1.2M+365%

EPS (diluted)$0.02—

Cash & equivalents$22.8M-65.9%

Total debt$17.4M-35.6%

Total equity$372.2M+5.6%

Total assets$400.9M+1.5%

Operating cash flow-$491.0K-128%

CapEx$167.0K-4.6%

Free cash flow-$658.0K-142%

Market cap$1.34B+33.1%

Enterprise value$1.34B+38.1%

P/S13.5×+0.6×

Gross margin66.9%—

Operating margin-16.7%—

Net margin-68.7%—

FCF margin-15.9%+18.7pp

Return on equity-14.5%-4.7pp

Debt / equity0×0.0×

Current ratio7.3×+2.6×

Reported directly by BioLife Solutions in its filing.

Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition.

The official record: BioLife Solutions’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and see it in context, right in your chat.

What is BioLife Solutions's investments - gross unrealized losses?: BioLife Solutions (BLFS) reported investments - gross unrealized losses of $57.93M in Q1 2026.
How has BioLife Solutions's investments - gross unrealized losses changed year-over-year?: BioLife Solutions's investments - gross unrealized losses increased by 479.6% year-over-year, from $10M to $57.93M.